Hikma Pharmaceuticals PLC
LSE:HIK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
UK |
|
Keller Group PLC
LSE:KLR
|
UK |
|
Beijing Kingsoft Office Software Inc
SSE:688111
|
CN |
|
Lar Espana Real Estate SOCIMI SA
MAD:LRE
|
ES |
|
S
|
SDI Group PLC
LSE:SDI
|
UK |
|
5
|
5I5j Holding Group Co Ltd
SZSE:000560
|
CN |
|
V
|
Vitruvio Real Estate SOCIMI SA
MAD:YVIT
|
ES |
|
M
|
Minesto AB
STO:MINEST
|
SE |
|
B
|
Broad Enterprise Co Ltd
TSE:4415
|
JP |
|
Fsilon Furnishing and Construction Materials Corp
SSE:605318
|
CN |
|
Aedge Group Ltd
SGX:XVG
|
SG |
|
Trade Desk Inc
NASDAQ:TTD
|
US |
Wall Street
Price Targets
HIK Price Targets Summary
Hikma Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for
HIK
is 2 320.5 GBX
with a low forecast of 1 616 GBX and a high forecast of 2 782.5 GBX.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HIK's stock price target?
Price Target
2 320.5
GBX
According to Wall Street analysts, the average 1-year price target for
HIK
is 2 320.5 GBX
with a low forecast of 1 616 GBX and a high forecast of 2 782.5 GBX.
What is Hikma Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
Hikma Pharmaceuticals PLC's revenue is
10%.
The projected
CAGR
for the next 3 years is
6%.
What is Hikma Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Hikma Pharmaceuticals PLC's operating income is
14%.
The projected
CAGR
for the next 3 years is
5%.
What is Hikma Pharmaceuticals PLC's Net Income forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Hikma Pharmaceuticals PLC's net income is
14%.
The projected
CAGR
for the next 3 years is
9%.
